Prospective, Multi-Center Study Using Bearing nsPVA Embolization Particles for the Treatment of uTErine fibRoids With Uterine Artery Embolization
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult women ≥ 18 years old at the time of enrollment.
• Subject has symptomatic uterine fibroid(s), suitable to embolization.
• Subject provides written informed consent.
Locations
Other Locations
Australia
The Alfred Health
RECRUITING
Sydney
Contact Information
Primary
Irene Coughlin
irene.coughlin@merit.com
6175435665
Backup
Vicky Brunk
vicky.brunk@merit.com
Time Frame
Start Date: 2024-08-22
Estimated Completion Date: 2025-10
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Merit Medical Systems, Inc.